479 related articles for article (PubMed ID: 28835305)
1. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
Hernandez JM; Paty J; Price IM
CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
[No Abstract] [Full Text] [Related]
3. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
Desjardins N; Jamoulle O; Taddeo D; Stheneur C
J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
[TBL] [Abstract][Full Text] [Related]
5. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
6. [Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting].
Nordholm-Carstensen A
Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394844
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital.
Habboushe J; Rubin A; Liu H; Hoffman RS
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):660-662. PubMed ID: 29327809
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
Richards JR
J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.
Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N
Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375
[TBL] [Abstract][Full Text] [Related]
10. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
Lee A; Coralic Z
Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
[TBL] [Abstract][Full Text] [Related]
11. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
[TBL] [Abstract][Full Text] [Related]
12. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid hyperemesis syndrome: A 6-year audit of adult presentations to an urban district hospital.
Rotella JA; Ferretti OG; Raisi E; Seet HR; Sarkar S
Emerg Med Australas; 2022 Aug; 34(4):578-583. PubMed ID: 35199462
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid hyperemesis: a case series.
Donnino MW; Cocchi MN; Miller J; Fisher J
J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
[TBL] [Abstract][Full Text] [Related]
17. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis.
Soh J; Kim Y; Shen J; Kang M; Chaudhry S; Chung TH; Kim SH; Hwang Y; Lim D; Khattak A; Frimer L; Yoo JW
PLoS One; 2024; 19(5):e0303205. PubMed ID: 38809874
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid hyperemesis syndrome: a review of the literature.
Deceuninck E; Jacques D
Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
[TBL] [Abstract][Full Text] [Related]
20. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Lee C; Greene SL; Wong A
Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
